Fluorescence-Guided Surgery—Illuminating the Limits of Cancer Therapeutics

JAMA Surgery 2026

View at publisher
Authors: Hidenori Tanaka, Shravan Gowrishankar, Eben L. Rosenthal
DOI: 10.1001/jamasurg.2025.6246
Cited by: 3
References: 6

Abstract

This Viewpoint describes the use of optically labeled therapeutic antibodies in fluorescence-guided surgery to advance understanding of drug delivery in cancer therapy.

Fields of Study & Subjects

Cancer Research and Treatments Nanoplatforms for cancer theranostics Advanced Fluorescence Microscopy Techniques

Publication details

Journal / source
JAMA Surgery
Publisher
American Medical Association (AMA)
Volume
161
Issue
3
Pages
221–221
Publication date
28 January 2026
Language
EN